Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: Identification of interleukin-10 as a major functional deactivator of human monocytes

Journal of Experimental Medicine

Volumn 184, Issue 1, 1996, Pages 51-60

  Brandtzaeg, Petter ^a   Osnes, Liv ^a   Øvstebø, Reidun ^a   Joø, Gun Britt ^a   Westvik, Åse Brit ^a   Kierulf, Peter ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ARTICLE; GRAM NEGATIVE SEPSIS; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; MENINGOCOCCEMIA; MONOCYTE; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; SEPTIC SHOCK; TARGET CELL;

EID: 0030036614     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.1.51     Document Type: Article

References (45)

1. Brandtzaeg, P., P. Kierulf, P. Gaustad, A. Skulberg, J.N. Bruun, S. Halvorsen, and E. Sorensen. 1989. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J. Infect. Dis. 159:195-204.
2. Brandtzaeg, P., R. Øvstebø, and P. Kierulf. 1995. Bacteremia and compartmentalization of LPS in meningococcal disease. In Bacterial Endotoxins: Lipopolysaccharides from Genes to Therapy. J. Levin, C.R. Alving, R.S. Munford, and H. Redl, editors. Wiley-Liss, New York. 219-233.
3. Brandtzaeg, P., and P. Kierulf. 1992. Endotoxin and meningococcemia. Intravascular inflammation induced by native endotoxin in man. In Bacterial Endotoxic Lipopolysaccharides. vol 2. J.L. Ryan and D.C. Morrison, editors. CRC Press, Boca Raton, FL 327-346.
4. van Deuren, M., J. van der Ven-Jongekrijg, A.K.M. Bartelink, R. van Dalen, R. W. Sauerwein, and J.W.M. van der Meer. 1995. Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections. J. Infect. Dis. 172:433-439.
5. Waage, A., A. Halstensen, and T. Espevik. 1987. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet. 1:355-357.
6. Girardin, E., G.E. Gray, J.M. Dayer, P. Roux-Lombard, The J5 study group, and P.H. Lambert. 1988. Tumor necrosis factor and interleukin 1 in serum of children with severe infectious purpura. N. Engl. J. Med. 319:397-400.
7. Waage, A., P. Brandtzaeg, A. Halstensen, P. Kierulf, and T. Espevik. 1989. The complex pattern of cytokines in serum from patients with meningococcal septic shock. J. Exp. Med. 169:333-338.
8. Halstensen, A., M. Ceska, P. Brandtzaeg, H. Redl, A. Naess, and A. Waage. 1993. Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease. J. Infect. Dis. 167:471-475.
9. Waring, P.M., L.J. Waring, and D. Metcalf. 1994. Circulating leukemia inhibitory factor levels correlate with disease severity in meningococcemia. J. Infect. Dis. 170:1224-1228.
10. Derkx, B., A. Marchant, M. Goldman, R. Bijlmer, and S. van Deventer. 1995. High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock. J. Infect. Dis. 171:229-232.
11. Gårdlund, B., J. Sjölin, A. Nilsson, M. Roll, C.J. Wickerts, and B. Wretlind. 1995. Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. J. Infect. Dis. 172:296-301.
12. Brandtzaeg, P., T.E. Mollnes, and P. Kierulf. 1989. Complement activation and endotoxin levels in systematic meningococcal disease. J. Infect. Dis. 160:58-65.
13. Brandtzaeg, P., P.M. Sandset, G.B. Joo, R. Ovstebo, and U. Abildgaard. 1989. The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide A in systemic meningococcal disease. Thromb. Res. 55:459-470.
14. Brandtzaeg, P., G.B. Joø, B. Brusletto, and P. Kierulf. 1990. Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease. Thromb. Res. 57:271-278.
15. Burrell, R. 1994. Human responses to bacterial endotoxin. Circ. Shock. 43:137-153.
16. Osterud, B., and T. Flaegstad. 1983. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to unfavourable prognosis. Thromb. Haemostasis. 49:5-7.
17. van Deuren, M., J. van der Ven-Jongekrijg, and P.N.M. Demacher. 1994. Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections. J Infect. Dis. 169:157-161.
18. Munoz, C., J. Carlet, C. Fitting, B. Misset, J.P. Blériot, and J.M. Cavaillon. 1991. Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Invest. 88:1747-1754.
19. Munoz, C., B. Misset, C. Fitting, J.P. Blériot, J. Carlet, and J.M. Cavaillon. 1991. Dissociation between plasma and monocyte-associated cytokines during sepsis. Eur. J. Immunol. 21: 2177-2184.
20. Granowitz, E.V., R. Porat, J.W. Mier, S.F. Orencole, G. Kaplanski, E.A. Lynch, K. Ye, E. Vannier, S.M. Wolff, and C.A. Dinarello. 1993. Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells. J. Immunol 151:1637-1645.
21. Hoøiby, E.A., G. Bjune, L.O. Frøholm, J. Eng, A. Halstensen, E. Rosenquist, E. Roønhild, and E. Wedege. 1991. The Norwegian meningococcal serogroup B outer membrane vesicle vaccine protection trials: case tracing, meningococcal antigen detection and serological diagnosis. NIPH (National Inst. Public Health) Ann. (Oslo). 14:107-121.
22. Brandtzaeg, P., K. Bryn, P. Kierulf, R. Øvstebø, E. Namork, B. Aase, and E. Jantzen. 1992. Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography, mass-spectrometry, ultracentrifugation, and electron microscopy. J. Clin. Invest. 89:816-823.
23. Brandtzaeg, P., K. Høgåsen, P. Kierulf, and T.E. Mollnes. 1996. The excessive complement activation in fulminant meningococcal septicemia is predominantly caused by alternative pathway activation. J. Infect. Dis. 173:647-655.
24. Osnes, L.T.N., Å.B. Westwik, and P. Kierulf. 1994. Procoagulant and profibrinolytic activities of cryopreserved human monocytes. Thromb. Res. 76:373-383.
25. Osnes, L.T.N., Å.B. Westvik, R. Øvstebø, G.B. Joø, C. Okkenhaug, and P. Kierulf. 1995. Lipolysaccharide activation of human monocytes mediated by CD 14, results in a co-ordinated synthesis of tissue factor, TNF-α and IL-6. J. Endotox Res. 2:27-35.
26. Hjort, P. 1957. Intermediate reactions in the coagulation of blood with tissue thromboplastin. Scand. J. Clin. Lab. Invest. Suppl. 27(9):1-183.
27. Jungi, T.W. 1990. A turbidimetric assay in an ELISA reader for determination of mononuclear phagocyte procoagulant activity. J. Immunol. Methods. 133:121-129.
28. Andersen, P., P. Kierulf, A.T. Elde, and H.G. Godal. 1980. The antithrombin and antiheparin effects of crude and highly purified a 1-acid glycoprotein. Thromb. Res. 19:401-408.
29. De Waal Malefyt, R., J. Abrams, B. Bennet, G.G. Figdor, and J.E. de Vries. 1991. Interleukin-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209-1220.
30. Ramani, M., V. Ollivier, F. Khechai, T. Vu, C. Ternisien, F. Briey, and D. de Prost. 1993. Interleukin-10 inhibits endotoxin-induced tissue factor mRNA production by human monocytes. FEBS (Fed. Eur. Biochem. Soc.) Lett. 334:114-116.
31. Jungi, T.W., M. Brcic, S. Eperon, and S. Albrecht. 1994. Transforming growth factor-beta and interleukin-10, but not interleukin-4, down-regulate procoagulant activity and tissue factor expression in human-derived macrophages. Thromb. Res. 76:463-474.
32. Wong, H.L., M.T. Lotze, L.M. Wahl, and S.M. Wahl. 1992. Administration of recombinant IL-4 to humans regulates gene expression, phenotype, and function in circulating monocytes. J. Immunol. 148:2118-2125.
33. Ramani, M., V. Ollivier, C. Ternisien, T. Vu, C. Elbim, J. Hakim, and D. de Prost. 1993. Interleukin 4 prevents the induction of tissue factor for mRNA in human monocytes in response to LPS or PMA stimulation. Br. J. Haematol. 85: 462-468.
34. Bogdan, C., J. Paik, Y. Vodovotz, and C. Nathan. 1992. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin 10. J. Biol. Chem. 267:23301-23308.
35. Marchant, A., J. Devière, B. Byl, D. De Groote, J.L. Vincent, and M. Goldman. 1994. Interleukin-10 production during septicaemia. Lancet. 343:707-708.
36. Marchant, A., C. Bruyns, P. Vandenabeele, D. Abramowicz, C. Gérard, A. Delvaux, P. Ghezzi, T. Velu, and M. Goldman. 1994. The protective role of interleukin-10 in endotoxin shock. In Bacterial Endotoxins: Basic Science to Antisepsis Strategies. J. Levin, S.J.H. van Deventer, T. van der Poll, and A. Sturk, editors. Wiley-Liss, New York. 417-423.
37. Lehmann, A.K., A. Halstensen, S. Sørnes, O. Røkke, and A. Waage. 1995. High levels of interleukin 10 in serum are associated with fatality in meningococcal disease. Infect. Immun. 63:2109-2112.
38. Cavaillon, J.M., C. Pitton, and C. Fitting. 1994. Endotoxin tolerance is not a LPS-spedfic phenomenon: partial mimicry with IL-1, IL-10, and TGFβ. J. Endotox Res. 1:21-29.
39. Von der Möhlen, M.A.M., A.N. Kimmings, N.I. Wedel, M.L.C.M. Mevissen, J. Jansen, N. Friedmann, T.J. Lorenz, B.J. Nelson, M.L. White, R. Bauer et al. 1995. Inhibition of endotoxin-induced cytokine release and neutrophil activation in humans by use of recombinant bactericidal/permeability-increasing protein. J. Infect. Dis. 172:144-151.
40. Gerard, C., C. Bruyns, A. Marchant, D. Abramowicz, P. Vandenabeele, A. Delvaux, W. Fiers, M. Goldman, and T. Velu. 1993. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. Exp. Med. 177:547-550.
41. Howard, M., T. Muchamuel, S. Andrade, and S. Menon. 1993. Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177:1205-1208.
42. Brandtzaeg, P., A. Halstensen, P. Kierulf, T. Espevik, and A. Waage. 1992. Molecular mechanisms in the compartmentalized inflammatory response presenting as meningococcal meningitis or septic shock. Microb. Pathog. 13:423-431.
43. McCarthy, P.L. 1994. Down-regulation of cytokine action. Bailliere's Clin. Haemathol 7:153-177.
44. Flegel, W.A., M.W. Baumstark, C. Weinstock, A. Berg, and H. Northoft. 1993. Prevention of endotoxin induced monokine release by human low- and high density lipoproteins and by apolipoprotein A-1. Infect. Immun. 61:5140-5146.
45. Wurfel, M.M., S.T. Kunitake, H. Lichenstein, J.P. Kane, and S.D. Wright. 1994. Lipolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J. Exp. Med. 180:1025-1035.